Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative MRI Assessment of Myotoxin-Induced Skeletal Muscle Damage of mdx Mice.

Muscle & nerve·2026
Same author

Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation.

Cell death & disease·2026
Same author

Genetic strategies for therapy of Duchenne muscular dystrophy.

Molecular therapy. Nucleic acids·2025
Same author

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle.

JCI insight·2025
Same author

The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Bidirectional role of Costameres in the pathophysiology of mdx skeletal muscles.

Human molecular genetics·2025

Related Experiment Video

Updated: Jun 5, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Duchenne muscular dystrophy models show their age.

Jeffrey S Chamberlain1

  • 1Departments of Neurology, Medicine, and Biochemistry, University of Washington, Seattle, WA 98195-7720, USA.

Cell
|December 25, 2010
PubMed
Summary

A novel mouse model closely mimics Duchenne muscular dystrophy (DMD) progression. This model highlights muscle stem cell activity as crucial for determining DMD severity, aiding therapy development.

Area of Science:

  • Biomedical Research
  • Animal Models
  • Genetics

Background:

  • Developing effective therapies for Duchenne muscular dystrophy (DMD) has been significantly hindered by the absence of suitable animal models.
  • Existing models often fail to fully recapitulate the complex pathology and disease progression observed in human DMD patients.

Discussion:

  • A newly developed mouse model, deficient in both dystrophin and telomerase, presents a significant advancement in DMD research.
  • This model accurately replicates the pathological hallmarks and disease trajectory of human DMD, offering unprecedented insights.

Key Insights:

  • Muscle stem cell activity emerges as a critical factor influencing the severity of Duchenne muscular dystrophy.
  • Understanding the role of muscle stem cells in this model provides a foundation for targeted therapeutic strategies.

More Related Videos

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Related Experiment Videos

Last Updated: Jun 5, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Outlook:

  • This advanced mouse model is poised to accelerate the discovery and testing of novel DMD therapies.
  • Further research utilizing this model could elucidate mechanisms to modulate muscle stem cell behavior for improved patient outcomes.